Further evidence of neuro-immune interplay has also emerged suggesting that use of biologic therapies such as TNF inhibitors can have central brain effects in people with RA well before a reduction of inflammation within affected joints occurs. This evidence concerns the gene TNF and rheumatoid arthritis.